These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 237568)

  • 21. Conformational and biological properties of glucagon fragments containing residues 1-17 and 19-29.
    Carrey EA; Epand RM
    Int J Pept Protein Res; 1983 Sep; 22(3):362-70. PubMed ID: 6313539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nalpha-trinitrophenyl glucagon: an inhibitor of glucagon-stimulated cyclic AMP production and its effects on glycogenolysis.
    Cote TE; Epand RM
    Biochim Biophys Acta; 1979 Jan; 582(2):295-306. PubMed ID: 216418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
    Hruby VJ
    Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin and glucagon attenuate the ability of cholera toxin to activate adenylate cyclase in intact hepatocytes.
    Irvine FJ; Houslay MD
    Biochem J; 1988 Apr; 251(2):447-52. PubMed ID: 2840894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of glucagon effects by changes in extracellular pH and calcium.
    Morand C; Remesy C; Demigne C
    Biochim Biophys Acta; 1988 Feb; 968(2):192-202. PubMed ID: 2829979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.
    Houslay MD; Metcalfe JC; Warren GB; Hesketh TR; Smith GA
    Biochim Biophys Acta; 1976 Jun; 436(2):489-94. PubMed ID: 179598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational and biological properties of di[delta-(5-nitro-2-pyrimidyl)ornithine 17,18]glucagon. Role of the arginine residues.
    Epand RM; Liepnieks JJ
    J Biol Chem; 1983 Jan; 258(1):203-7. PubMed ID: 6294099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an essential serine residue in glucagon: implication for an active site triad.
    Unson CG; Merrifield RB
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):454-8. PubMed ID: 8290548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation).
    Martin BR; Stein JM; Kennedy EL; Doberska CA; Metcalfe JC
    Biochem J; 1979 Nov; 184(2):253-60. PubMed ID: 230831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of rat liver adenylate cyclase by guanosine 5'-[beta,gamma-imido]triphosphate and glucagon. Existence of reversibly and irreversibly activated states of the stimulatory GTP-binding protein.
    Wong SK; Martin BR
    Biochem J; 1986 Feb; 233(3):845-51. PubMed ID: 3010941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment.
    Dipple I; Houslay MD
    Biochem J; 1978 Jul; 174(1):179-90. PubMed ID: 697751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboxyl group modification in glucagon.
    Epand RM; Epand RF
    Biochim Biophys Acta; 1972 Nov; 285(1):176-80. PubMed ID: 4653335
    [No Abstract]   [Full Text] [Related]  

  • 36. An improved synthesis of crystalline mammalian glucagon.
    Mojsov S; Merrifield RB
    Eur J Biochem; 1984 Dec; 145(3):601-5. PubMed ID: 6510418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of G-protein levels, ADP-ribosylation by cholera and pertussis toxins and the regulation of adenylyl cyclase activity in liver plasma membranes from lean and genetically diabetic (db/db) mice.
    Palmer TM; Houslay MD
    Biochim Biophys Acta; 1991 Oct; 1097(3):193-204. PubMed ID: 1932144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
    England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
    Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N alpha-Malto-glucagon and N alpha-malto, S-methyl methionine27-glucagon: preparation and characterization of two partial agonists.
    Coolican SA; Gurd RS
    Arch Biochem Biophys; 1984 Aug; 232(2):450-7. PubMed ID: 6380408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of epinephrine- and glucagon-sensitive adenylate cyclases of rat liver. Implications of alterations of enzymatic activities during preparation of particulate fractions and membranes.
    Katz MS; Kalish MI; Piñeyro MA; Gregerman RI
    Biochim Biophys Acta; 1978 May; 540(2):205-20. PubMed ID: 656470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.